Objective: To evaluate the effects of glucose-insulin-potassium (GIK) therapy on infarct size and left ventricular function when used as an adjuvant therapy to primary angioplasty.
Design: Prospective, randomized, double-blind, placebo-controlled study.
Setting: Cardiac intensive care unit at a university hospital.